Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma
type: MedicalStudy
description: Phase II Trial of Continuous Dose Temozolomide in Patients With Newly Diagnosed Pure and Mixed Anaplastic Oligodendroglioma
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2005-08
end date: 2016-01-06
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00400816
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: The Cleveland Clinic
study subject: Central Nervous System Tumors
study subject: Brain Tumor
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Central Nervous System Tumors
keywords: Brain Tumor

AI Analytics
type: Organization